
Fiona has a nursing background and has been working in the clinical trials arena for over 25 years. She has had all levels of trials experiece, initially as a clinical trials coordinator in a number of large teaching and private hospitals. She later worked within the pharmaceutical industry as a clinical research associate, and later a trials consultant, project managing many local and international multi-centre clinical trials. She left to take on a number of leadership initiatives, academic trial management and mentorship during a 12 year tenure at Neuroscience Trials Australia (NTA).
Fiona is currently the Platform Operations for the AVERT team where she is the Project Manager for the large international multicentre AVERT DOSE study, which is exploring the optimal dose of mobility training for stroke patients in the acute phase. She also plays a mentoring role working closely with academics, in relation to clinical trial design, managment and the day to day implementation of a number of projects. She brings an in depth understanding of regulatory clinical research requirements worldwide. She has a particular passion for working with clinicians, developing and managing academic trials from the concept stage, through to the final publication of results. She has a particular interest in mentorship and peer support, and is passionate about sharing expertise with new researchers to help them bring a particular regulatory rigour to their work.
Research Papers
Showing 10 of 20. VIEW ALL
-
Exploring Efficacy and Safety of Very Early Mobilization Within 24 Hours of Stroke Onset Versus Usual Stroke Unit Care (A Very Early Rehabilitation Trial, AVERT): Pre-specified Subgroup AnalysisStroke
-
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)(vol 86, pg 2138, 2016)NEUROLOGY
-
Prespecified dose-response analysis for a very early rehabilitation trial (AVERT)Neurology
-
Shorter, More Frequent Out of Bed Activity Very Early After Stroke (AVERT) is Associated With a Favorable Outcome at 3 MonthsStroke
-
A randomized controlled trial of very early rehabilitation in speech after stroke
-
Therapy fidelity and trial progress in the Very Early Rehabilitation in SpEech (VERSE) trialAnnual Scientific Meeting of the Stroke Society of Australasia
-
Economic Evaluation Plan (EEP) for A Very Early Rehabilitation Trial (AVERT): An international trial to compare the costs and cost-effectiveness of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset with usual stroke unit care
-
Therapy fidelity in the Very Early Rehabilitation in SpEech (VERSE) aphasia after stroke randomised controlled trial (RCT): Lessons learned and progress to dateSpeech Pathology Australia National Conference
-
The progress of a complex rehabilitation randomised controlled trial: Very Early Rehabilitation in SpEech (VERSE) after strokeSpeech Pathology Australia National Conference
-
Implementing a complex rehabilitation intervention in a stroke trial: a qualitative process evaluation of AVERTBMC Medical research methodology
Showing 10 of 20. VIEW ALL
Support us
Brain health affects all Australians. You can support our research by making a donation or a bequest.
- Give todayDonate now
- Pledge over timeJoin our brains trust
- Plan for the futureMake a gift in your will
Newsletter
Latest breakthroughs, news, events & more.